Cite
MLA Citation
J. Leonard et al.. “AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS.” Hematological oncology, vol. 37, n.d., pp. 114–115. http://access.bl.uk/ark:/81055/vdc_100086192616.0x000044